NL-OMON34977尚未招募2 期
Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new smoothie-style paediatric sip feed in children in need of oral nutritional support. - PAT-trial
Danone Research - Centre for Specialised Nutrition0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17(—)
入选标准
- •- Male and female subjects, aged 3-12 years (including 3 and 12 years) in need of oral nutritional support (subject can be current or new paediatric sip feed user).
- •- Subject requires a paediatric sip feed for at least 6 weeks.
- •- Both hospitalized subjects and out-patients.
- •- Stable health status and expected to remain stable throughout the study (in the opinion of the Health Care Professional).
- •- Written informed consent from parents/guardian and subject (if applicable according to local law).
排除标准
- •- Cow*s milk allergy, known inflammatory bowel disease, bowel resection.
- •- Subjects requiring a fibre-free diet.
- •- Known allergy for fruit (apple, pear, strawberry, raspberry, banana, apricot, lemon) and/or carrot.
- •- Subjects requiring an adult rather than a paediatric sip feed.
- •- Major renal dysfunction (if requiring, but not yet receiving, dialysis).
- •- Major hepatic dysfunction (e.g. hepatitis, congenital abnormalities affecting the liver).
- •- Major gastrointestinal intolerance (e.g. vomiting, diarrhoea).
- •- Inherited metabolic disorders, including galactosaemia.
- •- Use of parenteral feeding and/or enteral tube-feeding.
- •- Investigator's uncertainty about the willingness or ability of the child/carer to comply with the protocol requirements.
- •- Participation in any other study involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
研究者
相似试验
进行中(未招募)
Unknown
A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system as compared to a commercially available e-cigarette and combustible cigaretteicotine exposureISRCTN34837836JUUL Labs Inc28
招募中
1 期
Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer.Pancreatic exocrine insufficiencyMedDRA version: 20.0Level: LLTClassification code: 10073392Term: Pancreatic exocrine insufficiency Class: 10017947CTIS2023-507367-18-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela40
进行中(未招募)
不适用
An Open-label, Randomised, Three -Way, Cross-Over Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Formulations of RBP-6300 10mg in Healthy Volunteers under a Naltrexone Block in the Presence and Absence of Food.Maintenance/substitution agent for the treatment of opioid dependence.MedDRA version: 16.0Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 100000004873EUCTR2012-002408-42-GBReckitt Benckiser Pharmaceuticals Inc.
已完成
不适用
A randomized, open-label, three-way crossover clinical trial to compare safety and pharmacokinetic characteristics after single administration of Carol-F Tab, Advil Liqui-Gels and Brufen Tab 200 mg in healthy male volunteersDiseases of the nervous systemKCT0002017Dong-A University Hospital36
招募中
不适用
Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new paediatric sip feed in children in need of oral nutritional support.Children in need of oral nutritional supportNL-OMON26666Danone Research – Centre for Specialised Nutrition28
